HealthyDirect · GrowthFit for a long SIP
WhiteOak Capital Multi Cap Fund
WhiteOak Capital Mutual FundEquity Schemes - Multi Cap Fund3.1 years
The Scheme seeks to provide long-term capital appreciation / income by investing across market capitalisations and managing a diversified portfolio of Large Cap, Mid Cap and Small Cap Stock.
- NAV
- 16.075
- 30 Oct 2026
- 1Y
- -0.4%
- Trailing CAGR
- AUM
- ₹4,609.75 Cr
- 30 Sept 2026
- Volatility
- Medium
- 14.5% annualized
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 30 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · The fund beat the category median in 100% of rolling 3-year windows.
Fits if · Three-year return is above the category median.
Buy checklist
History depth
Watch
3.1 years - usable, still building a track record.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
0.89% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -16.9%. Ask whether you can hold through a similar fall.
Vs category
Pass
100% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Watch
Ashish Agrawal · 1.8 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 23.0% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 17%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y-0.4%
- 3Y+17.5%
- 5Yn/a
- 10Yn/a
- SI+16.5%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+2.1%
- 3Y+8.6%
- 5Yn/a
- 10Yn/a
- Since inception
- +16.5%
- Calendar-day CAGR
- Excess 1Y
- +3.8%
- Category median, same plan and option
- 3Y win rate
- +100%
- Windows beating the median
- 3Y percentile
- 89
- Vs comparable share classes
- SIP 3Y XIRR
- +8.6%
- Simulated monthly SIP
- Worst rolling 3Y
- +16.3%
- 24 daily-ending windows
- Median rolling 3Y
- +17.5%
- Calendar-day CAGR
- Positive rolling 5Y
- n/a
- 0 daily-ending windows
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -16.9%
- Worst peak-to-trough
- Current
- -6.8%
- Below last peak
- Current spell
- 60 days
- Days below latest peak
- Time below peak
- +80%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 8 days
- 62 recovered episodes
- Longest recovery
- 119 days
- Trough to prior peak
11 Dec 2024 – 27 Jun 2025
Trough 28 Feb 2025 · recovered in 119 days
-16.9%
17 Nov 2025 – 22 Jun 2026
Trough 23 Mar 2026 · recovered in 91 days
-15.0%
31 Aug 2026 – open
Trough 23 Oct 2026 · not recovered
-9.0%
15 Oct 2024 – 4 Dec 2024
Trough 13 Nov 2024 · recovered in 21 days
-6.7%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
89
Vs category
74
Consistency
100
Risk-adjusted
62
Drawdown
58
Mean
77
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- The fund beat the category median in 100% of rolling 3-year windows.
- Three-year return is above the category median.
- Risk-adjusted return sits above the documented risk-free proxy.
Portfolio
30 Sept 2026 · 225 holdings · top 10 are 23.0%.
- Top 5
- 15.7%
- Top 10
- 23.0%
- Largest holding
- 4.7%
- Effective holdings
- 93.2
ICICI Bank Ltd
Financial
4.7%
Others CBLO
Unspecified
4.2%
Bharti Airtel Ltd
Technology
2.5%
Nestle India Ltd
Consumer Staples
2.4%
HDFC Bank Ltd
Financial
2.0%
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Axis Multicap Fund
Axis Mutual Fund
- 1Y
- +3.8%
- 3Y
- +18.7%
- Vol
- 14.0%
- Max DD
- -18.1%
- Sharpe
- 0.69
- 3Y win
- +96%
- Lower volatility
- Higher trailing returns
Caveat: Deeper drawdown · Higher TER
UTI Multi Cap Fund
UTI Mutual Fund
- 1Y
- -4.6%
- 3Y
- n/a
- Vol
- 11.9%
- Max DD
- -14.1%
- Sharpe
- -0.30
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
Caveat: Higher TER · Lower trailing returns
Canara Robeco Multi Cap Fund
Canara Robeco Mutual Fund
- 1Y
- -4.8%
- 3Y
- +13.1%
- Vol
- 13.9%
- Max DD
- -18.3%
- Sharpe
- 0.52
- 3Y win
- 0%
- Lower volatility
- Lower TER
Caveat: Deeper drawdown · Lower trailing returns
Mirae Asset Multicap Fund
Mirae Asset Mutual Fund
- 1Y
- -6.8%
- 3Y
- +12.1%
- Vol
- 14.4%
- Max DD
- -18.2%
- Sharpe
- 0.45
- 3Y win
- 0%
- Lower volatility
- Lower TER
Caveat: Deeper drawdown · Lower trailing returns
Groww Multicap Fund
Groww Mutual Fund
- 1Y
- +10.3%
- 3Y
- n/a
- Vol
- 15.6%
- Max DD
- -16.5%
- Sharpe
- 0.31
- 3Y win
- n/a
- Shallower drawdown
Caveat: Higher volatility · Higher TER · Lower trailing returns